Evidence map›Paper›PMID 28008381›Full record

ArticleJournal of bone oncology2016

Pathologic fracture and healthcare resource utilisation: A retrospective study in eight European countries.

Jean-Jacques Body, Yves Pascal Acklin, Oliver Gunther, Guy Hechmati, João Pereira, Nikos Maniadakis, Evangelos Terpos, Jindrich Finek, Roger von Moos, Susan Talbot and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of bone oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 6 countries.

Jean-Jacques BodyCHU Brugmann, Université Libre de Bruxelles, Place A.Van Gehuchten 4, 1020 Brussels, Belgium.
Yves Pascal AcklinKantonsspital Graubünden, Loëstrasse 170, 7000 Chur, Switzerland.
Oliver GuntherCentre for Observational Research, Amgen Ltd, 1 Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, UK.
Guy HechmatiGlobal Health Economics, Amgen (Europe) GmbH, Dammstrasse 23, 6300 Zug, Switzerland.
João PereiraUniversidade NOVA de Lisboa, National School of Public Health, Avenida Padre Cruz 1600-560, Lisbon, Portugal.
Nikos ManiadakisDepartment of Health Services Management, National School of Public Health, 196 Alexandras Avenue, Athens, Greece.
Evangelos TerposUniversity of Athens School of Medicine, Alexandra University Hospital, V. Sofias and Lourou 1, 11528 Athens, Greece.
Jindrich FinekUniversity Hospital, Alej Svobody 923/80, 323 00 Pilsen, Czech Republic.
Roger von MoosKantonsspital Graubünden, Loëstrasse 170, 7000 Chur, Switzerland.
Susan TalbotCentre for Observational Research, Amgen Ltd, 1 Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, UK.
Harm SleeboomHAGA Hospital, Sportlaan 600, 2566 The Hague, The Netherlands.
Amgen (United Kingdom) · GBKantonsspital Graubünden · CHAlexandra Hospital · GRAmgen (Switzerland) · CHCentre Hospitalier Universitaire Brugmann · BEHaga Hospital · NLNational School of Public Health · GRUniversidade Nova de Lisboa · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSkeletal-related events (SREs; pathologic fracture [PF], spinal cord compression and radiation or surgery to bone) are common complications of bone metastases or bone lesions and can impose a considerable burden on patients and healthcare systems. In this study, the healthcare resource utilisation (HRU) associated with PFs in patients with bone metastases or lesions secondary to solid tumours or multiple myeloma was estimated in eight European countries.

methodsEligible patients were identified in Austria, the Czech Republic, Finland, Greece, Poland, Portugal, Sweden and Switzerland. HRU data were extracted from hospital charts from 3.5 months before the index PF (defined as a PF preceded by a 6.5-month period without a SRE) until 3 months after the last SRE during the study period. Changes from baseline in the number and duration of inpatient stays, number of outpatient visits and number of procedures provided were recorded.

resultsOverall, 118 patients with PFs of long bones (those longer than they are wide, e.g. the femur) and 241 patients with PFs of other bones were included. Overall, HRU was greater in patients with long bone PFs than in those with PFs of other bones. A higher proportion of patients with long bone PFs had multiple SREs (79.7%), and more of their SREs were considered to be linked (73.4%) compared with patients with PFs of other bones (51.0% and 47.2%, respectively).

conclusionThe increased number and duration of inpatient stays for PFs of long bones compared with those for PFs of other bones may be due in part to the requirement for complicated and lengthy rehabilitation in patients with long bone PFs. Implementing strategies to delay or reduce the number of PFs experienced by patients with bone metastases or lesions may therefore reduce the associated HRU and patient burden.

Indexed as

Bone metastasesHealthcare resource utilisationHRU, healthcare resource utilisationICD, International Classification of DiseasesPathologic fracturePF, pathologic fractureSD, standard deviationSkeletal-related eventSolid tumourSRE, skeletal-related event

Identifiers

PMID28008381
PMCPMC5154698
OpenAlexW2520348049

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.